Postes actifs de Gordon Brooks
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARMO BIOSCIENCES INC | Directeur/Membre du Conseil | 21/06/2018 | - |
| DERMIRA, INC. | Directeur/Membre du Conseil | 20/02/2020 | - |
| SIGILON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/08/2023 | - |
Historique de carrière de Gordon Brooks
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 3 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Bourse
- Insiders
- Gordon Brooks
- Expérience
